D-0440-2024 Class I Ongoing

Recalled by Eugia US LLC — East Windsor, NJ

FDA drug recall D-0440-2024 was initiated by Eugia US LLC on Feb 15, 2024 and is designated Class I. Reason for recall: Presence of Particulate Matter The recall status is ongoing. Affected quantity: 1,552 10ml x 25/carton.

Recall details

Product Type
Drugs
Report Date
Apr 17, 2024
Initiation Date
Feb 15, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,552 10ml x 25/carton

Product description

Methocarbamol Injection, USP 1000mg/10mL, (100mg/mL), 10 mL Single-Dose Vial packed 25 vials per carton, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor, NJ 08520, NDC 55150-223-10

Reason for recall

Presence of Particulate Matter

Distribution pattern

Nationwide in the USA

Code information

Lot #: 3MC23011, Exp 11/30/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0440-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0440-2024. Report a data issue: hello@regdatalab.com.